Marta Lawecka

Title: Marta Lawecka: Innovator in Pharmaceutical Chemistry

Introduction

Marta Lawecka is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic use. Her work has led to advancements in the synthesis of important pharmaceutical agents.

Latest Patents

Marta Lawecka holds 1 patent for her invention titled "Crystalline polymorphs of methanesulfonic acid addition salts of Imatinib." This invention pertains to the methanesulfonic acid addition salts of Imatinib and focuses on the synthesis of the crystalline α-form of Imatinib methanesulfonate. Additionally, the invention introduces a novel acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]benzamide with two molecules of methanesulfonic acid, along with its polymorphic forms and their pharmaceutical compositions.

Career Highlights

Marta Lawecka is affiliated with the Instytut Farmaceutyczny, where she conducts her research and development activities. Her expertise in pharmaceutical chemistry has positioned her as a key figure in her field, contributing to innovative solutions for drug formulation and delivery.

Collaborations

Marta has collaborated with notable colleagues, including Wojciech Szczepek and Dorota Samson-Lazinska. These partnerships have enhanced her research efforts and facilitated the advancement of her inventions.

Conclusion

Marta Lawecka's contributions to pharmaceutical chemistry exemplify her dedication to innovation and research. Her patent on Imatinib methanesulfonate showcases her ability to develop novel compounds that can significantly impact therapeutic practices.